Weize Li
Impact in
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
-
- Traditional Chinese Medicine Analysis
Papers in
-
- Advanced Drug Delivery Systems 5
- Advancements in Transdermal Drug Delivery 4
- Co-authors
- Ning Zhao (6 shared papers)Yongqiang Zhou (3 shared papers)Jianping Zhou (1 shared paper)Ting Liu (1 shared paper)Yong Zhang (1 shared paper)Lvyi Chen (1 shared paper)Lei Xu (1 shared paper)Yongqiang Zhou (1 shared paper)
- Journals
- Environmental Toxicology and Pharmacology (4 papers)European Journal of Pharmaceutical Sciences (3 papers)Organic & Biomolecular Chemistry (2 papers)REVIEWS ON ADVANCED MATERIALS SCIENCE (1 paper)Epigenomics (1 paper)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Weize Li
27 papers receiving 747 citations
Peers
Comparison fields: 5 of 90
- Pharmaceutical Science 325
- Complementary and alternative medicine 117
- Dermatology 91
- Pharmacology 50
- Biomaterials 71
Countries citing papers authored by Weize Li
This map shows the geographic impact of Weize Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weize Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weize Li more than expected).
Fields of papers citing papers by Weize Li
This network shows the impact of papers produced by Weize Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weize Li. The network helps show where Weize Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Weize Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 186 | |
| 2 | 2012 | 127 | |
| 3 | 2011 | 105 | |
| 4 | 2010 | 66 | |
| 5 | 2009 | 55 | |
| 6 | 2012 | 45 | |
| 7 | 2016 | 45 | |
| 8 | 2016 | 37 | |
| 9 | 2020 | 19 | |
| 10 | 2024 | 17 | |
| 11 | 2023 | 10 | |
| 12 | 2020 | 8 | |
| 13 | 2017 | 6 | |
| 14 | 2021 | 6 | |
| 15 | 2024 | 6 | |
| 16 | LncRNA-Anrel promotes the proliferation and migration of synovial fibroblasts through regulating miR-146a-mediated annexin A1 expression. | 2023 | 4 |
| 17 | 2024 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Weize Li
Weize Li is a scholar working on Molecular Biology, Pharmaceutical Science, Organic Chemistry, Pharmacology and Immunology, having authored 28 papers that have together received 768 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (5 papers), Advancements in Transdermal Drug Delivery (4 papers), Phytochemistry and Biological Activities (3 papers), Catalytic Cross-Coupling Reactions (2 papers), Alzheimer's disease research and treatments (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Biological and pharmacological studies of plants (2 papers). The work is most often cited by research in Pharmaceutical Science (325 citations), Complementary and alternative medicine (117 citations), Dermatology (91 citations), Pharmacology (50 citations) and Biomaterials (71 citations). Weize Li has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Ning Zhao, Yongqiang Zhou, Jianping Zhou, Ting Liu, Yong Zhang, Lvyi Chen, Lei Xu, Yongqiang Zhou, Xiao‐Ning Wang and Yang Zhong-lin. Their work appears in journals such as Environmental Toxicology and Pharmacology, European Journal of Pharmaceutical Sciences, Organic & Biomolecular Chemistry, REVIEWS ON ADVANCED MATERIALS SCIENCE and Epigenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.